98946-18-0

Basic information

• Product Name: tert-Butyl 2,2,2-trichloroacetimidate
• Synonyms: O-TERT BUTYL-2,2,2-TRICHLOROACETIMIDATE;N-(9-FLUORENYLMETHOXYCARBONYL)AMIDE;TERT-BUTYL 2,2,2-TRICHLOROACETIMIDATE;TBTA;T-BUTYL 2,2,2-TRICHLOROACETIMIDATE;TERT-BUTYL 2,2,2-TRICHLOROACETIMIDATE, 9 6%;T-BUTYL TRICHLOROACETIMIDATE;tert-Butyl 2,2,2-trichloroacetimidate 99%
• CAS NO: 98946-18-0
• Molecular Formula: C₆H₁₀Cl₃NO
• Molecular Weight: 218.51
• EINECS: -0
• Product Categories: Protection & Derivatization Reagents (for Synthesis);Synthetic Organic Chemistry
• Mol File: 98946-18-0.mol
• Article Data: 7

Chemical Properties

• Melting Point: 21 °C(lit.)
• Boiling Point: 65 °C11 mm Hg(lit.)
• Flash Point: 131 °F
• Appearance: Clear colorless to pale yellow/Liquid or Low Melting Crystalline Mass
• Density: 1.222
• Vapor Pressure: 1.058mmHg at 25°C
• Refractive Index: n20/D 1.456(lit.)
• Storage Temp.: 2-8°C
• Solubility: Soluble in organic solvents, cyclo hexane.
• PKA: 2.49±0.70(Predicted)
• Sensitive: Moisture Sensitive
• BRN: 1770049
• CAS DataBase Reference: tert-Butyl 2,2,2-trichloroacetimidate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl 2,2,2-trichloroacetimidate(98946-18-0)
• EPA Substance Registry System: tert-Butyl 2,2,2-trichloroacetimidate(98946-18-0)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 10-22-36/37/38
• Safety Statements: 26-37/39-16-36/37-24/25
• RIDADR: UN 1993 3/PG 3
• WGK Germany: 3
• F: 10-21
• TSCA: No
• HazardClass: 3.2
• PackingGroup: III
• Hazardous Substances Data: 98946-18-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
tert-Butyl 2,2,2-trichloroacetimidate is used as a reagent for the production of di-tert-butyl peroxide at a temperature of -5°C. tert-Butyl 2,2,2-trichloroacetimidate is essential in various chemical processes, particularly in the synthesis of complex organic molecules.
Used in the Synthesis of Caged Building Blocks:
In the field of organic chemistry, tert-Butyl 2,2,2-trichloroacetimidate is used as a key component in the synthesis of N-α-Fmoc-phospho(1-nitrophenylethyl-2-cyanoethyl)-L-serine, a caged building block. This caged compound is crucial for the development of complex molecular structures and has potential applications in various industries.
Used in the Conversion of Alcohols and Carboxylic Acids:
tert-Butyl 2,2,2-trichloroacetimidate is utilized as a reagent for the conversion of alcohols and carboxylic acids to their respective ethers and esters. This conversion is vital in the synthesis of a wide range of organic compounds, making it an essential tool in the field of organic chemistry.

InChI:InChI=1/C6H10Cl3NO/c1-5(2,3)11-4(10)6(7,8)9/h10H,1-3H3

Upstream product

• 865-47-4 potassium tert-butylate 
• 545-06-2 trichloroacetonitrile 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 2109-72-0 4-tert-butoxy-1-nitrobenzene 
• 2901-11-3 ester tertiobutylique de l'acide phenyl-2 propionique 
• 122977-53-1 1-O-benzyl-3-O-tert-butylglycerol 
• 90367-83-2 tert-butyl α-phenethyl ether 
• 3354-66-3 tert-butyl 2-phenylethyl ether 
• 53913-96-5 tert-butyl 2-(bromomethyl)acrylate 
• 142448-82-6 N,N'-Di-tert-butyl-2,4,6-trimethyl-benzene-1,3-diamine 
• 132903-76-5 (S)-2-Benzylamino-3-(tert-butyl-dimethyl-silanyloxy)-propionic acid tert-butyl ester 
• 135777-62-7 (4R)-1-benzyl-4-(t-butyloxycarbonyl)-3,3-difluoroazetidin-2-one 
• 122977-55-3 (S)-1-[Bis-(4-methoxy-phenyl)-methyl]-aziridine-2-carboxylic acid tert-butyl ester 
• 151436-20-3 tert-butyl (S)-2-[(tert-butoxycarbonyl)amino]pent-4-enoate 
• 133464-42-3 N-(Benzyloxycarbonyl)-O-allyl-L-serine tert-butyl ester 
• 144156-18-3 N²-(tert-Butoxycarbonyl)-N³-(benzyloxycarbonyl)-N³-(carboxymethyl)-L-2,3-diaminopropanoic acid α-tert-butyl δ-allyl ester 
• 144156-31-0 N-(Benzyloxycarbonyl)-O-(carboxymethyl)-L-serine di-tert-butyl ester 

Relevant articles and documents

COMPOUNDS CONTAINING POLYSUBSTITUTED BENZO[D][1,3]OXATHIOLE, BENZO[D][1,3]OXATHIOLE 3-OXIDE OR BENZO[D][1,3]OXATHIOLE 3,3-DIOXIDE AND METHODS/USES THEREOF AS AGONISTS OF G PROTEIN-COUPLED RECEPTOR 119

There are provided compounds having formula (I), in which: X1 and X2 are selected from certain combinations of O, S, SO and SO2; X3 is selected from CH, CF and N; X4 is selected from CH and N; X6, X6' and X6'' are selected from H, halogen, and certain alkyl, haloalkyl, alkoxy, hydroxyalkyl, and amide groups; X7 and X7' are selected from H, halogen, and certain alkyl, haloalkyl, alkoxy, hydroxyalkyl, aminoalkyl and amide groups, or both X7 and X7' together form a cycloalkyl or heterocycle; and A is selected from certain optionally substituted, alkoxy, piperazinyl and pyrrolidinyl groups. Also provided are compositions comprising these compounds, as well as uses/methods related thereto, including treatment of diseases and conditions associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders. (I)

Benzo [d] [1, 3] oxathiol, benzo [d] [1, 3] benzo [d] [1, 3] oxathiol 3 - oxide or 3, 3 - dioxide compounds and G protein-coupled receptor 119 oxathiol action of number as method/use

There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.

Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor

Abstract A practical and efficient synthesis of a complex chiral atropisomeric HIV integrase inhibitor has been accomplished. The combination of a copper-catalyzed acylation along with the implementation of the BI-DIME ligands for a ligand-controlled Suzuki cross-coupling and an unprecedented bis(trifluoromethane)sulfonamide-catalyzed tert-butylation renders the synthesis of this complex molecule robust, safe, and economical. Furthermore, the overall synthesis was conducted in an asymmetric and diastereoselective fashion with respect to the imbedded atropisomer. Atropselective: An efficient asymmetric synthesis of an atropisomeric HIV inhibitor has been accomplished. The combination of a copper-catalyzed acylation with the implementation of BI-DIME ligands for a ligand-controlled Suzuki cross-coupling and an unprecedented bis(trifluoromethane)sulfonamide-catalyzed tert-butylation renders the synthesis of this complex molecule robust, safe, and economical.

PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR

The present invention is directed to an improved process for the preparation of Compounds of Formula (I) or salts thereof which are useful in the treatment of HIV infection. In particular, the present invention is directed to an improved process for the preparation of (2S)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)- 2-methylquinolin-3-yl)acetic acid or salt thereof which is useful in the treatment of HIV infection. R4 is selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n) and (o); and R6 and R7 are each independently selected from H, halo and (C1-6) alkyl.

Bifunctional Metal Chelating Conjugates

The present invention is directed to metal chelating conjugates for use as metallopharmaceutical diagnostics or therapeutic agents. Specifically, conjugates of the present invention include a carrier, a metal coordinating moiety, and a urea linkage chemically linking the metal coordinating moiety to the carrier. The carrier is generally utilized for targeting the conjugate to a biological tissue or organ.

METAL COMPLEXES OF TETRAAZAMACROCYCLE DERIVATIVES

Improved methods for synthesizing bifunctional chelates of tetraazamacrocycle derivatives and intermediates thereof are disclosed as well as novel tetraazamacrocycle derivatives and intermediates thereof.

A NEW METHOD FOR THE PREPARATION OF TERTIARY BUTYL ETHERS AND ESTERS

T-butyl 2,2,2-trichloroacetimidate (1), readily prepared by addition of t-butanol to trichloroacetonitrile, is an efficient reagent for the preparation of t-butyl ethers and esters in the presence of a catalytic amount of boron trifluoride etherate.